Home
Class 12
BIOLOGY
In India how many recombinant therapeuti...

In India how many recombinant therapeutics are being presently marketed?

A

30

B

20

C

12

D

112

Text Solution

AI Generated Solution

The correct Answer is:
To answer the question about how many recombinant therapeutics are currently marketed in India, we can follow these steps: ### Step-by-Step Solution: 1. **Understanding Recombinant Therapeutics**: - Recombinant therapeutics are proteins produced using recombinant DNA technology. This involves combining DNA from different sources to create new therapeutic proteins. 2. **Types of Recombinant Therapeutics**: - These therapeutics can include recombinant hormones, interferons, and hematopoietic growth factors. Each of these plays a significant role in medical treatments. 3. **Current Market Status in India**: - As of the present time, it is important to gather data on the number of recombinant therapeutics that are actively marketed in India. 4. **Research Findings**: - After reviewing the current market data, it is found that a total of 12 recombinant therapeutics are currently being marketed in India. 5. **Conclusion**: - Therefore, the answer to the question is that there are 12 recombinant therapeutics being marketed in India. ### Final Answer: The number of recombinant therapeutics currently marketed in India is **12**. ---
Promotional Banner

Topper's Solved these Questions

  • MOCKTEST 23 : ZOOLOGY

    AAKASH INSTITUTE|Exercise EXAMPLE|7 Videos
  • Mocktest-04-zoology

    AAKASH INSTITUTE|Exercise EXAMPLE|22 Videos

Similar Questions

Explore conceptually related problems

How many recombinant therapeutics are being marketed in India ?

At present about a recombinant therapeutiecs have b of these are presently being marketed

How many recombinant therapeutics have been approved for human use all over the world?

How many recombinant therapeutics worldwide have been approved for human use ?

How many recombinant therapeutic have been approved for human - use all over the world ?

About (X) recombinant therapeutics have been approved for human use the world over out of which (Y) are presently being marketed in India